Anika Therapeutics | Ventas





Ventas Cambio Fecha
Abbott USD 11.46B 90M 2025-12
Agenus USD 24.07M 2.77M 2025-03
Agios Pharmaceuticals USD 12.9M 450K 2025-09
Anika Therapeutics USD 26.17M 12.58M 2025-03
Arrowhead Research USD 264.03M 7.56M 2025-12
Enanta Pharmaceuticals USD 16.96M 50.68M 2024-12
Halozyme Therapeutics USD 354M 148M 2025-09
Heron Therapeutics USD 32.81M 3.21M 2024-09
Insmed USD 142M 34.6M 2025-09
Integra LifeSciences USD 402.06M 13.54M 2025-09
Intrexon USD 717K 511K 2024-06
J&J USD 24.6B 610M 2025-12
Karyopharm Therapeutics USD 30.54M 8.24M 2024-12
Ligand Pharmaceuticals USD 115.46M 67.83M 2025-09
MacroGenics USD 72.84M 50.6M 2025-09
Merit Medical Systems USD 384.2M 1.7M 2025-09
Rigel Pharmaceuticals USD 55.31M 18.47M 2024-09
Sangamo BioSciences USD 356K 125K 2024-06
Sanofi EUR 11.3B 1.13B 2025-12
Smith & Nephew USD 2.96B 134M 2025-12
Stryker USD 7.2B 1.14B 2025-12
Surmodics USD 29.92M 96.16M 2024-12
Veracyte USD 131.9M 1.74M 2025-09
Xencor USD 21M 22.61M 2025-09
Zimmer Biomet Holdings USD 2.24B 240M 2025-12


Anika Therapeutics Ventas - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Feb 2026.